This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

An economic evaluation found that screening followed by intensive lifestyle intervention plus either semaglutide (Ozempic, ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...

Since 2023, the U.S. Food and Drug Administration (FDA) has not required animal testing, thanks in part to organoids, which ...

Hackensack Meridian Health's endocrinology team is working to bring advanced diabetes care closer to home for the state's 693 ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

At the risk of sounding like your cranky doctor (or mother), we’ll remind you that obesity is a gateway to chronic disease.

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.

Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.